Their findings demonstrated that combining elevated NT-proBNP and endostatin levels with clinical parameters a predictive accuracy of 80.6% for distinguishing ischemic from hemorrhagic strokes can be achieved. This evidence concerns the gene COL18A1 and hemorrhagic stroke.